SCOPUS 정보 검색 플랫폼

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 48, Issue 11, 2005, Pages 789-795

Erratum: Synthesis of tritium-labelled CHS 828 and its prodrug EB 1627 (Journals of Labelled Compounds and Radiopharmaceuticals (August 2005) 48 (789-795) DOI: 10.1002/jlcr.997);Synthesis of tritium labelled CHS 828 and its prodrug EB 1627

(4) Schou, Søren Christian a Hunneche, Charlotte Schou a Binderup, Ernst a Grue Sørensen, Gunnar a

a LEO PHARMA A S (Denmark)

Author keywords

CHS 828; EB 1627; Pd C catalysed tritiation; Prodrug; Tritio debromination; Tritium

Indexed keywords

CHS 828; DEBROMINATION; EB 1627; PD/C CATALYZED TRITIATION; PRODRUGS; PYRIDYL; RADIOCHEMICAL PURITY; TRITIATION; TRITIO-DEBROMINATION; TRITIUM GAS;

TRITIUM;

EB 1627; GUANIDINE DERIVATIVE; N [6 (4 CHLOROPHENOXY)HEXYL] N' CYANO N'' (4 PYRIDYL)GUANIDINE; PRODRUG; TRITIUM; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYST; DEBROMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SOLUBILITY; DRUG SYNTHESIS; ISOTOPE LABELING; RADIOCHEMISTRY;

EID: 27544473344 PISSN: 03624803 EISSN: 10991344 Source Type: Journal
DOI: 10.1002/jlcr.1045 Document Type: Erratum

Times cited : (3)

References (8)

1
- 0031472361
- Schou C, Ottosen ER, Petersen HJ, Björkling F, Latini S, Hjarnaa PV. Bioorg Med Chem Lett 1997; 7: 3095-3100.
- (1997) Bioorg Med Chem Lett , vol.7 , pp. 3095-3100
- Schou, C.¹ Ottosen, E.R.² Petersen, H.J.³ Björkling, F.⁴ Latini, S.⁵ Hjarnaa, P.V.⁶

2
- 0033571407
- Hjarnaa P-JV, Jonsson E, Latini S, Dhar S, Larsson R, Bramm E, Skov T, Binderup L. Cancer Res 1999; 59: 5751-5757.
- (1999) Cancer Res , vol.59 , pp. 5751-5757
- Hjarnaa, P.-J.V.¹ Jonsson, E.² Latini, S.³ Dhar, S.⁴ Larsson, R.⁵ Bramm, E.⁶ Skov, T.⁷ Binderup, L.⁸

3
- 0036716986
- Hovstadius P, Larsson R, Jonsson E, Skov T, Kissmeyer A-M, Krasilnikoff K, Bergh J, Karlsson MO, Lönnebo A, Ahlgren J. Clin Cancer Res 2002; 8: 2843-2850.
- (2002) Clin Cancer Res , vol.8 , pp. 2843-2850
- Hovstadius, P.¹ Larsson, R.² Jonsson, E.³ Skov, T.⁴ Kissmeyer, A.-M.⁵ Krasilnikoff, K.⁶ Bergh, J.⁷ Karlsson, M.O.⁸ Lönnebo, A.⁹ Ahlgren, J.¹⁰

4
- 18144420794
- DOI: 10.1016/j.bmcl.2005.03.064
- Binderup E, Björkling F, Hjarnaa PV, Latini S, Baltzer B, Carlsen M, Binderup L. Bioorg Med Chem Lett 2005; 15: 2491-2494. DOI: 10.1016/j.bmcl.2005. 03.064
- (2005) Bioorg Med Chem Lett , vol.15 , pp. 2491-2494
- Binderup, E.¹ Björkling, F.² Hjarnaa, P.V.³ Latini, S.⁴ Baltzer, B.⁵ Carlsen, M.⁶ Binderup, L.⁷

5
- 85167470682
- Binderup E, Björkling F, Hjarnaa PV, Sonne K, Latini S, Binderup L. Drugs Future 2004; 29 (Suppl. A): 379.
- (2004) Drugs Future , vol.29 , Issue.SUPPL. A , pp. 379
- Binderup, E.¹ Björkling, F.² Hjarnaa, P.V.³ Sonne, K.⁴ Latini, S.⁵ Binderup, L.⁶

6
- 4344575968
- DOI: 10.1097/01.cad.0000109324.56830.cl
- Gullbo J, Lövborg H, Dhar S, Lukinius A, Öberg F, Nilsson K, Björkling F, Binderup L, Nygren P, Larsson R. Anticancer Drugs 2004; 15: 45-54. DOI: 10.1097/01.cad.0000109324.56830.cl.
- (2004) Anticancer Drugs , vol.15 , pp. 45-54
- Gullbo, J.¹ Lövborg, H.² Dhar, S.³ Lukinius, A.⁴ Öberg, F.⁵ Nilsson, K.⁶ Björkling, F.⁷ Binderup, L.⁸ Nygren, P.⁹ Larsson, R.¹⁰

7
- 0034951948
- DOI: 10.1002/jlcr.469
- Peterson LA, Spratt TE, Shan W, Wang L, Subotkowski W, Roth R. J Label Compd Radiopharm 2001; 44: 445-450. DOI: 10.1002/jlcr.469.
- (2001) J Label Compd Radiopharm , vol.44 , pp. 445-450
- Peterson, L.A.¹ Spratt, T.E.² Shan, W.³ Wang, L.⁴ Subotkowski, W.⁵ Roth, R.⁶

8
- 85167471917
- Leo Pharmaceutical Products Ltd. A/S, Patent appl., WO02/42265, 2002
- Binderup E, Hjarnaa P-JV, Leo Pharmaceutical Products Ltd. A/S, Patent appl., WO02/42265, 2002.
- Binderup, E.¹ Hjarnaa, P.-J.V.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.